GlassScriptPhysician profile
Amanda K Allen
NPI 1174950638
$2,110.20
in general payments reported to CMS, 2019-2025
16 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Critical Care Medicine (Nurse Practitioner) provider received nationally (typical 2025 total: $118).
See the full distribution for Critical Care Medicine (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $445 · 2022: $328 · 2023: $586 · 2024: $644 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038 · Consulting Fee: $200 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.89 |
| Consulting Fee | $200.00 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $380.98 | 2022-2024 | Cardiomems, Mitraclip |
| Actelion Pharmaceuticals US, INC. | $362.39 | 2023-2024 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $271.64 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.21 | 2021-2025 | Jardiance |
| United Therapeutics Corporation | $232.97 | 2023-2024 | Tyvaso, Orenitram, Remodulin |
| Astrazeneca Pharmaceuticals LP | $136.48 | 2021 | |
| Medtronic, INC. | $119.09 | 2022 | |
| Merck Sharp & Dohme LLC | $98.29 | 2021-2024 | Winrevair |
| Janssen Pharmaceuticals, INC | $77.07 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.46 | 2021 | |
| Liquidia Technologies, INC. | $30.97 | 2025 | Yutrepia |
| Heartflow, INC. | $27.80 | 2025 | |
| Novartis Pharmaceuticals Corporation | $25.00 | 2023 | |
| Scpharmaceuticals INC. | $22.95 | 2025 | |
| Boston Scientific Corporation | $14.99 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daxor Corporation | $10.91 | 2025 | Bva-100 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.